Breast Neoplasms: all 12,820 studies

Page 35 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.

• This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast CancerCompletedNCT03099174Phase 1Results posted
• Decision-aid on Breast Cancer ScreeningCompletedNCT03097653Not applicableResults posted
• Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast CancerCompletedNCT03096847Phase 3Results posted
• Pembrolizumab With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall DiseaseCompletedNCT03095352Phase 2Results posted
• Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and NeratinibCompletedNCT03094052Phase 2Results posted
• TACTIC - TAA Specific Cytotoxic T Lymphocytes in Patients With Breast CancerCompletedNCT03093350Phase 2Results posted
• A Study of AK-01 (LY3295668) in Solid TumorsCompletedNCT03092934Phase 1/2Results posted
• PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast SurgeryCompletedNCT03084536Phase 2Results posted
• Compare Efficacy, Safety and Immunogenicity of HLX02 and Herceptin in Previously Untreated HER2 +Overexpressing Metastatic Breast CancerCompletedNCT03084237Phase 3Results posted
• Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast CancerCompletedNCT03078751Phase 2Results posted
• Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized TrialActive, not recruitingNCT03075072Not applicableResults posted
• PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical LesionsActive, not recruitingNCT03070236Not applicableResults posted
• Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor CellsTerminatedNCT03070002Phase 2Results posted
• SV-BR-1-GM in Metastatic or Locally Recurrent Breast CancerCompletedNCT03066947Phase 1/2Results posted
• Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering Contralateral Prophylactic MastectomyCompletedNCT03061175Not applicableResults posted
• Study of CB-839 in Combination w/ Paclitaxel in Participants of African Ancestry and Non-African Ancestry With Advanced Triple Negative Breast Cancer (TNBC)CompletedNCT03057600Phase 2Results posted
• Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior TreatmentsCompletedNCT03056755Phase 2Results posted
• Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast CancerCompletedNCT03054363Phase 1/2Results posted
• Phase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BCTerminatedNCT03051672Phase 2Results posted
• A Randomized Phase II Study Of Eribulin Mesylate With or Without Pembrolizumab For Metastatic Hormone Receptor Positive Breast CancerCompletedNCT03051659Phase 2Results posted
• A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/RibociclibTerminatedNCT03050398Phase 3Results posted
• Pilot Study of Cabazitaxel and Paclitaxel in HER2 Negative Breast CancerCompletedNCT03048942Phase 2Results posted
• Efficacy of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Breast CancerCompletedNCT03045653Phase 2Results posted
• Pembrolizumab and Capecitabine in Treating Patients With Locally Advanced or Metastatic Triple Negative or Hormone-Refractory Breast Cancer That Cannot Be Removed by SurgeryStatus unknownNCT03044730Phase 2Results posted
• Study of Stereotactic Radiotherapy for Breast CancerTerminatedNCT03043794Phase 2Results posted
• CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast CancerActive, not recruitingNCT03032406Phase 2Results posted
• A Study Of Pembrolizumab In Combination With Trastuzumab-DM1CompletedNCT03032107Phase 1Results posted
• ENGAGED 2 Study: Experiences With Mammography Screening and Breast Density 2CompletedNCT03029286Not applicableResults posted
• Trial to Evaluate Efficacy and Safety of Pembrolizumab and Gemcitabine in HER2-negative ABCCompletedNCT03025880Phase 2Results posted
• Pembrolizumab in Combination With Olaparib in Advanced BRCA-mutated or HDR-defect Breast CancerCompletedNCT03025035Phase 2Results posted
• Pilot Study of Paclitaxel Plus Pembrolizumab in Metastatic HER2-Negative Breast CancerCompletedNCT03018080Phase 2Results posted
• Long Term Use of SAVI SCOUT: Pilot StudyCompletedNCT03015649Not applicableResults posted
• CISPLATIN + AZD-1775 In Breast CancerCompletedNCT03012477Phase 2Results posted
• Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast CancerActive, not recruitingNCT03012100Phase 2Results posted
• Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast CancerCompletedNCT03007979Phase 2Results posted
• A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of DarolutamideCompletedNCT03004534Early Phase 1Results posted
• SBRT and Oncolytic Virus Therapy Before Pembrolizumab for Metastatic TNBC and NSCLCCompletedNCT03004183Phase 2Results posted
• A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast CancerCompletedNCT02999477Phase 1Results posted
• Study of Dual-energy (DE) Contrast-enhanced (CE) Digital MammographyCompletedNCT02995980Not applicableResults posted
• Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the BreastCompletedNCT02993159Phase 2Results posted
• CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast CancerCompletedNCT02992067Results posted
• TAK-228 Plus Tamoxifen in Patients With ER-Positive, HER2-negative Breast CancerCompletedNCT02988986Phase 2Results posted
• Study Evaluating Efficacy and Safety of SAR566658 Treatment in Patients With CA6 Positive Metastatic Triple Negative Breast CancerTerminatedNCT02984683Phase 2Results posted
• GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Negative-Breast CancerTerminatedNCT02983604Phase 1/2Results posted
• A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid TumorsCompletedNCT02983045Phase 1/2Results posted
• Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast CancerCompletedNCT02981303Phase 2Results posted
• Phase I/II Study of U3-1402 in Subjects With Human Epidermal Growth Factor Receptor 3 (HER3) Positive Metastatic Breast CancerCompletedNCT02980341Phase 1/2Results posted
• Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC)TerminatedNCT02978716Phase 2Results posted
• Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast CancerCompletedNCT02971761Phase 2Results posted
• Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast CancerTerminatedNCT02964507Phase 1Results posted
• Empowering Latinas to Obtain Breast Cancer ScreeningsCompletedNCT02964234Not applicableResults posted
• Oxybutynin Chloride in Managing Hot FlashesCompletedNCT02961790Phase 3Results posted
• Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast CaActive, not recruitingNCT02957968Phase 2Results posted
• Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant TherapyCompletedNCT02956473Not applicableResults posted
• Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast CancerActive, not recruitingNCT02955394Phase 2Results posted
• MEtronomic TrEatment Option in Advanced bReast cAncerCompletedNCT02954055Phase 2Results posted
• Fulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast CancerCompletedNCT02953860Phase 2Results posted
• SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and CyclophosphamideCompletedNCT02953340Phase 3Results posted
• Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)CompletedNCT02950259Phase 1Results posted
• Microfluidic Device to Diagnose Leptomeningeal Metastasis in Breast CancerCompletedNCT02948751Results posted
• Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast CancerActive, not recruitingNCT02947685Phase 3Results posted
• Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBCCompletedNCT02941926Phase 3Results posted
• Implementing Systematic Distress Screening in Breast CancerCompletedNCT02941614Results posted
• Vaccination of Triple Negative Breast Cancer PatientsCompletedNCT02938442Phase 1/2Results posted
• Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.TerminatedNCT02936206Phase 1Results posted
• Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With ReconstructionActive, not recruitingNCT02927912Phase 2Results posted
• Real-Time Assessment Of Breast Cancer Surgical Specimen Margins With Nonlinear MicroscopyTerminatedNCT02926729Not applicableResults posted
• A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine in Combination With Atezolizumab or Atezolizumab-Placebo in Participants With Human Epidermal Growth Factor-2 (HER2) Positive Locally Advanced or Metastatic Breast Cancer (BC) Who Received Prior Trastuzumab and Taxane Based TherapyCompletedNCT02924883Phase 2Results posted
• Accelerated Radiation Therapy (ART) to the Breast and Nodal StationsActive, not recruitingNCT02917421Phase 1/2Results posted
• A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and CapecitabineCompletedNCT02915744Phase 3Results posted
• Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus PalbociclibCompletedNCT02913430Early Phase 1Results posted
• Behavioral and Psychological Impact of Returning Breast Density Results to LatinasCompletedNCT02910986Not applicableResults posted
• Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer PatientsCompletedNCT02910219Phase 2Results posted
• Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast CancerTerminatedNCT02907918Phase 2Results posted
• Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast CancerCompletedNCT02898207Phase 1Results posted
• A Study to Evaluate the Efficacy and Safety of Pertuzumab + Trastuzumab + Docetaxel Versus Placebo + Trastuzumab + Docetaxel in Previously Untreated Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast CancerCompletedNCT02896855Phase 3Results posted
• Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast CancerTerminatedNCT02892734Phase 2Results posted
• Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant TreatmentCompletedNCT02891681Not applicableResults posted
• Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast CancerActive, not recruitingNCT02883062Phase 2Results posted
• Multicenter Phase II Study of Apatinib in Patients With Advanced Breast Cancer(CABC006)CompletedNCT02878057Phase 2Results posted
• Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast CancerTerminatedNCT02876640Phase 1Results posted
• Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast CancerCompletedNCT02876302Phase 2Results posted
• Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine CancerTerminatedNCT02874430Phase 2Results posted
• Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic ChemotherapyCompletedNCT02872103Phase 3Results posted
• Palbociclib With Everolimus + Exemestane In BCCompletedNCT02871791Phase 1/2Results posted
• REduction of Physical Inactivity Facing the CAncerCompletedNCT02867475Not applicableResults posted
• Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast CancerCompletedNCT02860000Phase 2Results posted
• The Digital Breast Tomosynthesis Trial in BergenCompletedNCT02835625Not applicableResults posted
• L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer PatientsCompletedNCT02834403Phase 1/2Results posted
• A Study of TAK-659 in Combination With Nivolumab in Participants With Advanced Solid TumorsTerminatedNCT02834247Phase 1Results posted
• A Study of Pre-Operative Treatment With Cryoablation and Immune Therapy in Early Stage Breast CancerCompletedNCT02833233Not applicableResults posted
• Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast CancerActive, not recruitingNCT02827877Phase 2Results posted
• Expectations and Priorities of Elderly Patients for a First Medical Treatment for CancerCompletedNCT02821793Results posted
• Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)CompletedNCT02819518Phase 3Results posted
• Benefit of a Diagnostic MRI in Case of Pathological Nipple Discharge With Normal Mammography / UltrasoundCompletedNCT02819362Results posted
• Diagnostic Utility of MRI in Female Patients With Nipple Discharge: A Prospective TrialTerminatedNCT02818946Not applicableResults posted
• Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast CancerTerminatedNCT02810873Not applicableResults posted
• Real-time Intraoperative Breast Cancer Visualization for Margin AssessmentTerminatedNCT02807597Phase 1/2Results posted
• Neoadjuvant Tamoxifen in Locally Advanced Breast Cancer in a Low/Middle Income CountryCompletedNCT02806544Phase 2Results posted
• To Enhance Breast Cancer Survivorship of Asian AmericansCompletedNCT02803593Not applicableResults posted

← Breast Neoplasms overview